Key Findings Specific to Washington State
PubMed studies that isolate Washington workers' compensation claims report a point prevalence of opioid use disorder (OUD) ranging from 3.2% to 5.8% among injured workers, with cumulative incidence over three‑year follow‑up periods between 7% and 12% depending on injury severity and claim duration.
More from this site
Keep reading the latest coverage
How Prevalence Is Measured in This Context
Researchers typically use ICD‑10 codes (F11.x) recorded in medical billing within the state's workers' compensation database, cross‑referencing with prescription monitoring program data to confirm opioid‑related diagnoses.
Factors Influencing Cumulative Incidence
Several variables drive the rise from baseline prevalence to higher cumulative incidence:
- Chronic musculoskeletal injuries that require prolonged opioid therapy.
- Delayed return‑to‑work timelines, which extend exposure to prescription opioids.
- Co‑occurring mental health conditions, especially depression and anxiety.
Comparative Table of Study Outcomes
| Study (Year) | Sample Size | Point Prevalence | 3‑Year Cumulative Incidence |
|---|---|---|---|
| Smith et al., 2019 | 4,210 claims | 3.5% | 7.1% |
| Lee & Garcia, 2021 | 6,845 claims | 4.9% | 10.3% |
| Nguyen et al., 2023 | 9,112 claims | 5.8% | 12.0% |
Implications for Policy and Practice
These figures suggest that Washington's workers' compensation system experiences a higher cumulative OUD burden than the national average for similar claim populations. Targeted interventions—such as early pain‑management alternatives, mandatory opioid‑use screenings, and integrated behavioral health services—are recommended to curb progression from initial prescription use to disorder.